Refractory Thyroid Carcinomas: Experience of the Medical Oncology Department of Hassan II Hospital in Fez, Morocco

Lamyae Nouiakh; Karima Oualla; Hajar Ouahbi; Soumia Berrad; Hayat Erraichi; Lamiae Amaadour; Zineb Benbrahim; Samia Arifi; Meryem boubou; Nawfel Mellas

doi:10.23958/ijirms/vol05-i12/1003

Open Access Publication ISSN: 2455-8737 |

Total : PDF: 213 | Total views: 213

Original Article | Open Access

Vol. 5 No. 12 (2020) | Page No.: 606 - 610 | https://doi.org/10.23958/ijirms/vol05-i12/1003

Refractory Thyroid Carcinomas: Experience of the Medical Oncology Department of Hassan II Hospital in Fez, Morocco

Lamyae Nouiakh⁺⁻
Karima Oualla⁺⁻
Hajar Ouahbi⁺⁻
Soumia Berrad⁺⁻
Hayat Erraichi⁺⁻
Lamiae Amaadour⁺⁻
Zineb Benbrahim⁺⁻
Samia Arifi⁺⁻
Meryem boubou⁺⁻
Nawfel Mellas⁺⁻

Department of Medical Oncology, Hassan II University Hospital, Fes, Morocco

Department of Radiology, Hassan II University Hospital, Fes, Morocco

Department of Medical Oncology, Hassan II University Hospital, Fes, Morocco

Google Scholar

Published: 2020-12-13

Abstract

Background: Refractory thyroid carcinomas are rare. The prognosis of these carcinomas depends on several factors including the histological type and the evolutionary stage. Aim: Determine the epidemiological, pathological and prognostic characteristics of refractory thyroid carcinomas and to focus on the therapeutic modalities used for the treatment of these cancers. Methods: Our work is a retrospective descriptive study on 28 cases collected in the medical oncology department of Hassan II hospital in Fez over a period of 7 years, from January 2012 to January 2019. The statistical analysis of the results was done by SPSS version 23. Survival was calculated by the Kaplan-Meier method. Results: The average age was 57.3 years, with a sex ratio F/M of 1.3. Thyroid nodule and multi-hetero nodular goiter were present in 32.1% and 28.5% of cases, respectively. The most common carcinoma was the papillary (36%) followed by the vesicular (25%), the anaplastic (25%) and the medullary (14%). The first line treatment was based on SORAFENIB (administered to 40% of patients) and on conventional chemotherapy (60%). After an average number of 4 courses, the objective response rate was 47%. The median of progression-free survival was 15 months and that of overall survival was 25 months. Conclusion: Overall, refractory thyroid cancers are rare. Systemic treatments have evolved considerably in recent years with the development of targeted therapies, pending the advent of immunotherapy that could improve the prognosis of patients with these cancers, particularly those with anaplastic carcinoma.

Keywords: thyroid, refractory carcinoma, prognosis, Morocco

Downloads

Download data is not yet available.

Most read articles by the same author(s)

Nisrine Acharfi, Karima Oualla, Hajar Ouahbi, Zineb Benbrahim, Samia Arifi, Hind EL Fatemi, Meryem Boubou, Chahrazed Bouchikhi, Abdelaziz Banani, Nawfel Mellas, Malignant Transformation of Ovarian Mature Teratoma: About a Case and Literature Review , International Journal of Innovative Research in Medical Science: Vol. 4 No. 11 (2019)
Ibtihal Ahalli, Karima Oualla, Loubna Hejjane, Raihana Boujarnija, Kaouthar Messoudi, Adil Mai, Fatima Zahrae Er Reggad, Lamiaa Amaadour, Zineb Benbrahim, Samia Arifi, Badr Alami, Laila Chbani, Nawfel Mellas, Pazopanib in Pulmonary Epithelioid Hemangioendothelioma: Report of a Case , International Journal of Innovative Research in Medical Science: Vol. 5 No. 02 (2020)
Hayat Erraichi, Niaina Ezra Randriamanovontsoa, Valère Litique, Jean-Marc Limacher, S. Berrad, Karima Oualla, Lamiae Ammadour, Zineb Benbrahim, S. Arifi, Nawfal Mellas, Ovarian Cancer Revealed by Paraneoplastic Cerebellar Degeneration Anti-Yo Positive: A Case Report , International Journal of Innovative Research in Medical Science: Vol. 5 No. 12 (2020)
Nisrine Acharfi, Raihana Boujarnija, Kaouthar Messoudi, Khadija Darif, Hajar Ouahbi, Imane Ouafki, Lamiae Amaadour, Karima Oualla, Zineb Benbrahim, Samia Arifi, Amal Douida, Hind EL Fatemi, Meryem Boubou, Chahrazed Bouchikhi, Abdelaziz Banani, Nawfel Mellas, Signet Ring Cell Carcinoma of the Breast: About A Case and Literature Review , International Journal of Innovative Research in Medical Science: Vol. 5 No. 03 (2020)

How to Cite

Nouiakh, L., Karima Oualla, Ouahbi, H., Berrad, S., Erraichi, H., Amaadour, L., … Nawfel Mellas. (2020). Refractory Thyroid Carcinomas: Experience of the Medical Oncology Department of Hassan II Hospital in Fez, Morocco. International Journal of Innovative Research in Medical Science, 5(12), 606–610. https://doi.org/10.23958/ijirms/vol05-i12/1003

Copyrights & License

Copyright © 2020 Lamyae Nouiakh Karima Oualla Hajar Ouahbi Soumia Berrad Hayat Erraichi Lamiae Amaadour Zineb Benbrahim Samia Arifi Meryem boubou Nawfel Mellas this is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

This work is licensed under a Creative Commons Attribution 4.0 International License.